These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
811 related items for PubMed ID: 12494894
1. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms. Nasir A, Fernandez PM, Chughtai OR, Kaiser HE. In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894 [Abstract] [Full Text] [Related]
2. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II. Moyad MA. Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882 [Abstract] [Full Text] [Related]
3. Colorectal cancer and non-steroidal anti-inflammatory drugs. Ota S, Bamba H, Kato A. Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434 [Abstract] [Full Text] [Related]
5. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma]. Tuynman JB, Hulscher JB, Steller EP, van Lanschot JJ, Richel DJ. Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2207-12. PubMed ID: 14640057 [Abstract] [Full Text] [Related]
6. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Gupta RA, Dubois RN. Nat Rev Cancer; 2001 Oct 08; 1(1):11-21. PubMed ID: 11900248 [Abstract] [Full Text] [Related]
10. Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugs. Shaheen NJ, Straus WL, Sandler RS. Cancer; 2002 Feb 15; 94(4):950-63. PubMed ID: 11920463 [Abstract] [Full Text] [Related]
11. [Clinical application of cyclooxygenase-2 inhibitors]. Dzielska-Olczak M, Olczak S. Pol Merkur Lekarski; 2001 Jun 15; 10(60):480-2. PubMed ID: 11503270 [Abstract] [Full Text] [Related]
13. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G, Ash C, Hay K, Redston M, Kwong E, Hancock B, Mak T, Kargman S, Evans JF, Gallinger S. Cancer Res; 2001 Aug 15; 61(16):6131-6. PubMed ID: 11507063 [Abstract] [Full Text] [Related]
14. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas. Adegboyega PA, Ololade O, Saada J, Mifflin R, Di Mari JF, Powell DW. Clin Cancer Res; 2004 Sep 01; 10(17):5870-9. PubMed ID: 15355919 [Abstract] [Full Text] [Related]
15. [COX-2 inhibitor and colon cancer]. Tsujii M. Gan To Kagaku Ryoho; 2001 Nov 01; 28(12):1799-805. PubMed ID: 11729471 [Abstract] [Full Text] [Related]
16. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Chun KS, Surh YJ. Biochem Pharmacol; 2004 Sep 15; 68(6):1089-100. PubMed ID: 15313405 [Abstract] [Full Text] [Related]
17. Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives. Dermond O, Rüegg C. Drug Resist Updat; 2001 Oct 15; 4(5):314-21. PubMed ID: 11991685 [Abstract] [Full Text] [Related]
18. Prevention of colorectal cancer through the use of COX-2 selective inhibitors. Peek RM. Cancer Chemother Pharmacol; 2004 Sep 15; 54 Suppl 1():S50-6. PubMed ID: 15309515 [Abstract] [Full Text] [Related]